EyePoint, Inc. (EYPT)
13.40
+0.07
(+0.53%)
USD |
NASDAQ |
May 07, 16:00
13.40
0.00 (0.00%)
After-Hours: 17:20
EyePoint SG&A Expense (TTM) : 37.79M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Ocular Therapeutix, Inc. | 87.80M |
| Regeneron Pharmaceuticals, Inc. | 2.715B |
| ACADIA Pharmaceuticals, Inc. | 548.89M |
| Vertex Pharmaceuticals, Inc. | 1.357B |
| Cellectar Biosciences, Inc. | 11.48M |